Quanterix Corporation Share-based Payment Arrangement, Expense
Quanterix Corporation (QTRX) reported Share-based Payment Arrangement, Expense of $4.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-10
- Quanterix Corporation share-based payment arrangement, expense for the quarter ending 2026-06-30 was $4.21M, a 21.61% decline year-over-year.
- Quanterix Corporation share-based payment arrangement, expense for the quarter ending 2026-03-31 was $4.53M, a 17.10% decline year-over-year.
- Quanterix Corporation share-based payment arrangement, expense for the quarter ending 2025-12-31 was $4.42M, a 8.72% decline year-over-year.
- Quanterix Corporation share-based payment arrangement, expense for the quarter ending 2025-09-30 was $5.47M, a 17.44% increase year-over-year.
- Quanterix Corporation share-based payment arrangement, expense for fiscal 2025 was $20.72M, a 3.66% increase from fiscal 2024.
- Quanterix Corporation share-based payment arrangement, expense for fiscal 2024 was $19.99M, a 18.81% increase from fiscal 2023.
- Quanterix Corporation share-based payment arrangement, expense for fiscal 2023 was $16.82M, a 9.36% increase from fiscal 2022.
- Quanterix Corporation share-based payment arrangement, expense for fiscal 2022 was $15.38M, a 3.71% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.21M 10-Q · filed 2026-08-10 | $8.74M 10-Q · filed 2026-08-10 | $13.15M derived: sum of 3 quarters · filed 2026-08-10 | $18.62M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $4.53M 10-Q · filed 2026-05-06 | $8.94M derived: sum of 2 quarters · filed 2026-05-06 | $14.41M derived: sum of 3 quarters · filed 2026-05-06 | $19.79M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.88M derived: sum of 2 quarters · filed 2026-03-02 | $15.26M derived: sum of 3 quarters · filed 2026-08-10 | $20.72M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $5.47M 10-Q · filed 2025-11-10 | $10.84M derived: sum of 2 quarters · filed 2026-08-10 | $16.30M 10-Q · filed 2025-11-10 | $21.14M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $5.37M 10-Q · filed 2026-08-10 | $10.83M 10-Q · filed 2026-08-10 | $15.67M derived: sum of 3 quarters · filed 2026-08-10 | $20.33M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $5.46M 10-Q · filed 2026-05-06 | $10.30M derived: sum of 2 quarters · filed 2026-05-06 | $14.96M derived: sum of 3 quarters · filed 2026-05-06 | $20.18M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $9.49M derived: sum of 2 quarters · filed 2026-03-02 | $14.72M derived: sum of 3 quarters · filed 2026-03-02 | $19.99M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $4.66M 10-Q · filed 2025-11-10 | $9.88M derived: sum of 2 quarters · filed 2025-11-10 | $15.15M 10-Q · filed 2025-11-10 | $19.48M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-06-30 | $5.23M 10-Q · filed 2025-08-07 | $10.49M 10-Q · filed 2025-08-07 | $14.82M derived: sum of 3 quarters · filed 2026-03-02 | $19.16M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2024-03-31 | $5.26M 10-Q · filed 2025-05-12 | $9.59M derived: sum of 2 quarters · filed 2026-03-02 | $13.94M derived: sum of 3 quarters · filed 2026-03-02 | $18.14M derived: sum of 4 quarters · filed 2026-03-02 | ||||
| 2023-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $8.67M derived: sum of 2 quarters · filed 2026-03-02 | $12.88M derived: sum of 3 quarters · filed 2026-03-02 | $16.82M 10-K · filed 2026-03-02 | $16.76M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $4.34M 10-Q · filed 2024-12-26 | $4.34M 10-Q · filed 2023-11-08 | $8.55M derived: sum of 2 quarters · filed 2024-12-26 | $12.50M 10-Q · filed 2024-12-26 | $12.44M 10-Q · filed 2023-11-08 | $16.10M derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-06-30 | $4.21M 10-Q/A · filed 2024-12-26 | $4.19M 10-Q · filed 2023-08-08 | $8.15M 10-Q/A · filed 2024-12-26 | $8.10M 10-Q · filed 2023-08-08 | $11.76M derived: sum of 3 quarters · filed 2025-03-17 | $14.52M derived: sum of 4 quarters · filed 2025-03-17 | ||
| 2023-03-31 | $3.94M 10-Q/A · filed 2024-12-26 | $3.90M 10-Q · filed 2023-05-09 | $7.55M derived: sum of 2 quarters · filed 2025-03-17 | $10.31M derived: sum of 3 quarters · filed 2025-03-17 | $15.50M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2022-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $6.37M derived: sum of 2 quarters · filed 2025-03-17 | $11.56M derived: sum of 3 quarters · filed 2025-03-17 | $15.38M 10-K · filed 2025-03-17 | $15.44M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $2.77M 10-Q · filed 2023-11-08 | $7.95M derived: sum of 2 quarters · filed 2023-11-08 | $11.78M 10-Q · filed 2023-11-08 | $16.71M derived: sum of 4 quarters · filed 2024-12-26 | ||||
| 2022-06-30 | $5.19M 10-Q · filed 2023-08-08 | $9.01M 10-Q · filed 2023-08-08 | $13.94M derived: sum of 3 quarters · filed 2024-12-26 | $17.95M derived: sum of 4 quarters · filed 2024-12-26 | ||||
| 2022-03-31 | $3.83M 10-Q · filed 2023-05-09 | $8.76M derived: sum of 2 quarters · filed 2024-12-26 | $12.77M derived: sum of 3 quarters · filed 2024-12-26 | $16.42M derived: sum of 4 quarters · filed 2024-12-26 | ||||
| 2021-12-31 | $4.93M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $8.94M derived: sum of 2 quarters · filed 2024-12-26 | $12.59M derived: sum of 3 quarters · filed 2024-12-26 | $15.97M 10-K/A · filed 2024-12-26 | ||||
| 2021-09-30 | $4.01M 10-Q · filed 2022-11-09 | $7.66M derived: sum of 2 quarters · filed 2022-11-09 | $11.04M 10-Q · filed 2022-11-09 | $14.17M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $3.65M 10-Q · filed 2022-08-08 | $7.04M 10-Q · filed 2022-08-08 | $10.16M derived: sum of 3 quarters · filed 2023-03-06 | $12.53M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $3.39M 10-Q · filed 2022-05-10 | $6.51M derived: sum of 2 quarters · filed 2023-03-06 | $8.88M derived: sum of 3 quarters · filed 2023-03-06 | $11.38M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $5.49M derived: sum of 2 quarters · filed 2023-03-06 | $7.99M derived: sum of 3 quarters · filed 2023-03-06 | $10.10M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $2.36M 10-Q · filed 2021-11-04 | $4.86M derived: sum of 2 quarters · filed 2021-11-04 | $6.97M 10-Q · filed 2021-11-04 | $8.64M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $2.50M 10-Q · filed 2021-08-05 | $4.61M 10-Q · filed 2021-08-05 | $6.29M derived: sum of 3 quarters · filed 2022-03-01 | $8.11M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $2.11M 10-Q · filed 2021-05-06 | $3.78M derived: sum of 2 quarters · filed 2022-03-01 | $5.61M derived: sum of 3 quarters · filed 2022-03-01 | $7.21M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $3.50M derived: sum of 2 quarters · filed 2022-03-01 | $5.10M derived: sum of 3 quarters · filed 2022-03-01 | $6.39M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $1.83M 10-Q · filed 2020-11-06 | $3.43M derived: sum of 2 quarters · filed 2020-11-06 | $4.71M 10-Q · filed 2020-11-06 | $6.20M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $1.60M 10-Q · filed 2020-08-04 | $2.88M 10-Q · filed 2020-08-04 | $4.38M derived: sum of 3 quarters · filed 2021-03-05 | $6.24M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $1.28M 10-Q · filed 2020-05-07 | $2.77M derived: sum of 2 quarters · filed 2021-03-05 | $4.64M derived: sum of 3 quarters · filed 2021-03-05 | $5.53M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $3.36M derived: sum of 2 quarters · filed 2021-03-05 | $4.25M derived: sum of 3 quarters · filed 2021-03-05 | $4.88M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $1.87M 10-Q · filed 2019-11-08 | $2.76M derived: sum of 2 quarters · filed 2019-11-08 | $3.39M 10-Q · filed 2019-11-08 | $4.13M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $890.00K 10-Q · filed 2019-08-06 | $1.53M 10-Q · filed 2019-08-06 | $2.26M derived: sum of 3 quarters · filed 2020-03-13 | $2.89M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | $636.00K 10-Q · filed 2019-05-10 | $1.37M derived: sum of 2 quarters · filed 2020-03-13 | $2.00M derived: sum of 3 quarters · filed 2020-03-13 | $2.55M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.36M derived: sum of 2 quarters · filed 2020-03-13 | $1.91M derived: sum of 3 quarters · filed 2020-03-13 | $2.17M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $623.00K 10-Q · filed 2018-11-07 | $1.17M derived: sum of 2 quarters · filed 2018-11-07 | $1.43M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $550.00K 10-Q · filed 2018-08-10 | $808.00K 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | $258.00K 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | $928.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |